Javascript must be enabled to continue!
Detection of aac(3)IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso
View through CrossRef
Background
.
Klebsiella pneumoniae
is the second most frequently isolated bacterium in medical bacteriology laboratories after
Escherichia coli
. It can be responsible for many infections, including urinary tract infections and pneumonia. The treatment of these infections is often prolonged because of the resistance of this bacterium to antibiotics. The production of aminoglycoside-modifying enzymes and the production of RNA methylases confer resistance to aminoglycosides. In Burkina Faso, studies on bacterial resistance to aminoglycosides, an antibiotic regularly prescribed and consumed by patients, are limited; hence, the purpose of this study was to determine the prevalence of aminoglycoside resistance genes in
K. pneumoniae
isolated from urine and pus samples.
Methods and Findings.
A total of 150
Klebsiella
strains from pus and urine cultures were collected from October 2018 to June 2019 in two hospitals in Ouagadougou and were included in this study. After plating on Muller–Hinton medium to obtain pure colonies, antibiotic susceptibility testing was performed with aminoglycosides,
β
-lactams, fluoroquinolones and sulphonamides. PCR testing for the
phoE
gene allowed genotypic identification of
K. pneumoniae
. PCRs were then performed on strains with at least one aminoglycoside resistance for identification of the
aac(6′)-Ib
,
aac(3)-IIc
and
armA
resistance genes.
Antibiotic susceptibility testing showed that 38.67% (58/150) of the strains were resistant to tobramycin, 28.67% (43/150) to gentamicin, 10.00% (15/150) to netilmicin, 8.67% (13/150) to kanamycin, 4.67% (7/150) to amikacin and 0.67% (1/150) to neomycin. Of the 63 strains (42.66%) with at least 1 aminoglycoside resistance, the resistance genes,
aac(3)-IIc
and
aac(6′)-Ib
, were detected in 49 strains (77.77%) and 39 strains (61.90%), respectively, and 34 strains (53.97%) had both genes. The
armA
gene was present in 19.04% of the strains (12/63).
Conclusion.
Aminoglycoside resistance in
K. pneumoniae
strains in this study is primarily due to
aac(3)-IIc
and
aac(6′)-Ib
acetyltransferases. Although
armA
RNA methylase genes are less frequent, increased surveillance is necessary due to the high level of aminoglycoside resistance conferred by this gene.
Title: Detection of aac(3)IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso
Description:
Background
.
Klebsiella pneumoniae
is the second most frequently isolated bacterium in medical bacteriology laboratories after
Escherichia coli
.
It can be responsible for many infections, including urinary tract infections and pneumonia.
The treatment of these infections is often prolonged because of the resistance of this bacterium to antibiotics.
The production of aminoglycoside-modifying enzymes and the production of RNA methylases confer resistance to aminoglycosides.
In Burkina Faso, studies on bacterial resistance to aminoglycosides, an antibiotic regularly prescribed and consumed by patients, are limited; hence, the purpose of this study was to determine the prevalence of aminoglycoside resistance genes in
K.
pneumoniae
isolated from urine and pus samples.
Methods and Findings.
A total of 150
Klebsiella
strains from pus and urine cultures were collected from October 2018 to June 2019 in two hospitals in Ouagadougou and were included in this study.
After plating on Muller–Hinton medium to obtain pure colonies, antibiotic susceptibility testing was performed with aminoglycosides,
β
-lactams, fluoroquinolones and sulphonamides.
PCR testing for the
phoE
gene allowed genotypic identification of
K.
pneumoniae
.
PCRs were then performed on strains with at least one aminoglycoside resistance for identification of the
aac(6′)-Ib
,
aac(3)-IIc
and
armA
resistance genes.
Antibiotic susceptibility testing showed that 38.
67% (58/150) of the strains were resistant to tobramycin, 28.
67% (43/150) to gentamicin, 10.
00% (15/150) to netilmicin, 8.
67% (13/150) to kanamycin, 4.
67% (7/150) to amikacin and 0.
67% (1/150) to neomycin.
Of the 63 strains (42.
66%) with at least 1 aminoglycoside resistance, the resistance genes,
aac(3)-IIc
and
aac(6′)-Ib
, were detected in 49 strains (77.
77%) and 39 strains (61.
90%), respectively, and 34 strains (53.
97%) had both genes.
The
armA
gene was present in 19.
04% of the strains (12/63).
Conclusion.
Aminoglycoside resistance in
K.
pneumoniae
strains in this study is primarily due to
aac(3)-IIc
and
aac(6′)-Ib
acetyltransferases.
Although
armA
RNA methylase genes are less frequent, increased surveillance is necessary due to the high level of aminoglycoside resistance conferred by this gene.
Related Results
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Phenotypic and Molecular Characterization of the blaTEM Gene in Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae
Abstract
Introduction
There has been a notable rise in antibiotic resistance among enterobacteria. This issue is primarily attributed to the emergence of extended-spectrum beta-lac...
Detection of aac3IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Detection of aac3IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Background: Klebsiella pneumoniae is the second most frequently isolated bacterium in medical bacteriology laboratory after Escherichia coli. It can be responsible for many infecti...
Detection of aac3IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Detection of aac3IIc, aac(6)Ib and armA gene encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Background: Klebsiella pneumoniae is the second most frequently isolated bacterium in medical bacteriology laboratory after Escherichia coli. It can be responsible for many infecti...
Detection of aac3IIc, aac(6)Ib and armA genes encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
Detection of aac3IIc, aac(6)Ib and armA genes encoding aminoglycoside resistance in Klebsiella pneumoniae in Burkina Faso.
BackgroundKlebsiella pneumoniae is the second most frequently isolated bacterium in medical bacteriology laboratory after Escherichia coli. It can be responsible for many infection...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Entreprendre au Burkina Faso : quelles sont les contraintes au développement des entreprises et les facteurs de succès pour entreprendre au Burkina Faso, un pays pauvre et enclavé au coeur de l’Afrique?
Entreprendre au Burkina Faso : quelles sont les contraintes au développement des entreprises et les facteurs de succès pour entreprendre au Burkina Faso, un pays pauvre et enclavé au coeur de l’Afrique?
(English) This thesis examines the constraints to business development and identifies the key success factors for entrepreneurship in Burkina Faso, a landlocked and poor country lo...
ANTIBACTERIAL ACTIVITY OF RED GINGER (Zingiber officinale var. rubrum) EXTRACTS AS GROWTH INHIBITORS OF Klebsiella pneumoniae
ANTIBACTERIAL ACTIVITY OF RED GINGER (Zingiber officinale var. rubrum) EXTRACTS AS GROWTH INHIBITORS OF Klebsiella pneumoniae
Pneumonia, a significant global health concern, is caused by Klebsiella pneumoniae infection. Antibiotic use is the primary treatment for K. pneumoniae infection; however, inapprop...
301 ACUTE ACALCULOUS CHOLECYSTITIS AND CARDIOVASCULAR DISEASE, WHICH CAME FIRST?
301 ACUTE ACALCULOUS CHOLECYSTITIS AND CARDIOVASCULAR DISEASE, WHICH CAME FIRST?
Abstract
Background
The existence of a close association between disease of the biliary tract and heart's disease is known from ...

